Marc Becker
Overview
Marc Becker received an average of $2M in total compensation, including $399K in salary, at Concert Pharmaceuticals from 2018 to 2021. Marc Becker also received $2M at CRISPR Therapeutics AG in 2016.
Source: SEC filings on April 26, 2022, April 28, 2020, April 29, 2019, and April 18, 2017.
Related executives
We found 13 more executives who work or worked at Concert Pharmaceuticals and CRISPR Therapeutics AG.
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
James Kasinger
CRISPR Therapeutics AG
General Counsel
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Roger Tung
Concert Pharmaceuticals
Chief Executive Officer
James Cassella
Concert Pharmaceuticals